Trends in prescribing gastroprotective agents with non steroidal anti-inflammatory drugs in an orthopaedic outpatient unit of a tertiary care hospital

B. Raghavendra, Narendranath Sanji, Sheetal D. Ullal, R. Kamath, M. R.S.M. Pai, S. Kamath, A. Savur

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: Non steroidal anti-inflammatory drugs (NSAIDs) are the most common drugs prescribed the world over. However, they have many adverse effects, especially gastrointestinal toxicity, which is the reason for their frequent co-prescription with gastroprotective agents. Misoprostol has been specifically approved for prevention of NSAID-induced ulcers in high-risk patients. Proton pump inhibitors too have been used with outstanding efficacy for this indication. Aim: This drug utilization study was conducted to study the co-administration of NSAIDs with gastroprotective drugs in an Orthopaedic Outpatient Unit of an urban, tertiary care, teaching hospital. Settings and Design: A prospective drug utilization study. Patients and Methods: This was a prospective study conducted in the Orthopaedic Outpatient Unit of an urban, tertiary care, teaching hospital, for six months. Prescriptions were collected from patients attending the Orthopaedic Outpatients Department. The co-prescription of NSAIDs with gastroprotective agents was analyzed. Results: A total of 1008 prescriptions were studied; 884 prescriptions contained NSAIDs, out of which 288 (32.58%) were co-prescribed with gastroprotective agents. The most common gastroprotective agents combined with NSAIDs were Proton pump inhibitors (81.19%). H2 receptor blockers were a distant second (17.81%), while Misoprostol was not used at all. Conclusion: NSAIDs are commonly co-prescribed with gastroprotectives. Diclofenac is the most commonly co-prescribed NSAID, while Naproxen was least commonly co-prescribed with gastroprotectives. Proton pump inhibitors were most frequently used, while Misoprostol was not used at all, probably because of its higher costs, frequent side effects and the need for multiple daily dosing.

Original languageEnglish
Pages (from-to)1553-1556
Number of pages4
JournalJournal of Clinical and Diagnostic Research
Volume3
Issue number3
Publication statusPublished - 15-07-2009
Externally publishedYes

Fingerprint

Orthopedics
Non-Steroidal Anti-Inflammatory Agents
Tertiary Healthcare
Tertiary Care Centers
Anti-Inflammatory Agents
Outpatients
Pharmaceutical Preparations
Prescriptions
Misoprostol
Proton Pump Inhibitors
Drug Utilization
Teaching Hospitals
Teaching
Histamine H2 Receptors
Naproxen
Diclofenac
Ulcer
Toxicity
Prospective Studies
Costs and Cost Analysis

All Science Journal Classification (ASJC) codes

  • Clinical Biochemistry

Cite this

@article{7e85e368703349c3b25e921c8f4c2569,
title = "Trends in prescribing gastroprotective agents with non steroidal anti-inflammatory drugs in an orthopaedic outpatient unit of a tertiary care hospital",
abstract = "Background: Non steroidal anti-inflammatory drugs (NSAIDs) are the most common drugs prescribed the world over. However, they have many adverse effects, especially gastrointestinal toxicity, which is the reason for their frequent co-prescription with gastroprotective agents. Misoprostol has been specifically approved for prevention of NSAID-induced ulcers in high-risk patients. Proton pump inhibitors too have been used with outstanding efficacy for this indication. Aim: This drug utilization study was conducted to study the co-administration of NSAIDs with gastroprotective drugs in an Orthopaedic Outpatient Unit of an urban, tertiary care, teaching hospital. Settings and Design: A prospective drug utilization study. Patients and Methods: This was a prospective study conducted in the Orthopaedic Outpatient Unit of an urban, tertiary care, teaching hospital, for six months. Prescriptions were collected from patients attending the Orthopaedic Outpatients Department. The co-prescription of NSAIDs with gastroprotective agents was analyzed. Results: A total of 1008 prescriptions were studied; 884 prescriptions contained NSAIDs, out of which 288 (32.58{\%}) were co-prescribed with gastroprotective agents. The most common gastroprotective agents combined with NSAIDs were Proton pump inhibitors (81.19{\%}). H2 receptor blockers were a distant second (17.81{\%}), while Misoprostol was not used at all. Conclusion: NSAIDs are commonly co-prescribed with gastroprotectives. Diclofenac is the most commonly co-prescribed NSAID, while Naproxen was least commonly co-prescribed with gastroprotectives. Proton pump inhibitors were most frequently used, while Misoprostol was not used at all, probably because of its higher costs, frequent side effects and the need for multiple daily dosing.",
author = "B. Raghavendra and Narendranath Sanji and Ullal, {Sheetal D.} and R. Kamath and Pai, {M. R.S.M.} and S. Kamath and A. Savur",
year = "2009",
month = "7",
day = "15",
language = "English",
volume = "3",
pages = "1553--1556",
journal = "Journal of Clinical and Diagnostic Research",
issn = "2249-782X",
publisher = "Journal of Clinical and Diagnostic Research",
number = "3",

}

Trends in prescribing gastroprotective agents with non steroidal anti-inflammatory drugs in an orthopaedic outpatient unit of a tertiary care hospital. / Raghavendra, B.; Sanji, Narendranath; Ullal, Sheetal D.; Kamath, R.; Pai, M. R.S.M.; Kamath, S.; Savur, A.

In: Journal of Clinical and Diagnostic Research, Vol. 3, No. 3, 15.07.2009, p. 1553-1556.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Trends in prescribing gastroprotective agents with non steroidal anti-inflammatory drugs in an orthopaedic outpatient unit of a tertiary care hospital

AU - Raghavendra, B.

AU - Sanji, Narendranath

AU - Ullal, Sheetal D.

AU - Kamath, R.

AU - Pai, M. R.S.M.

AU - Kamath, S.

AU - Savur, A.

PY - 2009/7/15

Y1 - 2009/7/15

N2 - Background: Non steroidal anti-inflammatory drugs (NSAIDs) are the most common drugs prescribed the world over. However, they have many adverse effects, especially gastrointestinal toxicity, which is the reason for their frequent co-prescription with gastroprotective agents. Misoprostol has been specifically approved for prevention of NSAID-induced ulcers in high-risk patients. Proton pump inhibitors too have been used with outstanding efficacy for this indication. Aim: This drug utilization study was conducted to study the co-administration of NSAIDs with gastroprotective drugs in an Orthopaedic Outpatient Unit of an urban, tertiary care, teaching hospital. Settings and Design: A prospective drug utilization study. Patients and Methods: This was a prospective study conducted in the Orthopaedic Outpatient Unit of an urban, tertiary care, teaching hospital, for six months. Prescriptions were collected from patients attending the Orthopaedic Outpatients Department. The co-prescription of NSAIDs with gastroprotective agents was analyzed. Results: A total of 1008 prescriptions were studied; 884 prescriptions contained NSAIDs, out of which 288 (32.58%) were co-prescribed with gastroprotective agents. The most common gastroprotective agents combined with NSAIDs were Proton pump inhibitors (81.19%). H2 receptor blockers were a distant second (17.81%), while Misoprostol was not used at all. Conclusion: NSAIDs are commonly co-prescribed with gastroprotectives. Diclofenac is the most commonly co-prescribed NSAID, while Naproxen was least commonly co-prescribed with gastroprotectives. Proton pump inhibitors were most frequently used, while Misoprostol was not used at all, probably because of its higher costs, frequent side effects and the need for multiple daily dosing.

AB - Background: Non steroidal anti-inflammatory drugs (NSAIDs) are the most common drugs prescribed the world over. However, they have many adverse effects, especially gastrointestinal toxicity, which is the reason for their frequent co-prescription with gastroprotective agents. Misoprostol has been specifically approved for prevention of NSAID-induced ulcers in high-risk patients. Proton pump inhibitors too have been used with outstanding efficacy for this indication. Aim: This drug utilization study was conducted to study the co-administration of NSAIDs with gastroprotective drugs in an Orthopaedic Outpatient Unit of an urban, tertiary care, teaching hospital. Settings and Design: A prospective drug utilization study. Patients and Methods: This was a prospective study conducted in the Orthopaedic Outpatient Unit of an urban, tertiary care, teaching hospital, for six months. Prescriptions were collected from patients attending the Orthopaedic Outpatients Department. The co-prescription of NSAIDs with gastroprotective agents was analyzed. Results: A total of 1008 prescriptions were studied; 884 prescriptions contained NSAIDs, out of which 288 (32.58%) were co-prescribed with gastroprotective agents. The most common gastroprotective agents combined with NSAIDs were Proton pump inhibitors (81.19%). H2 receptor blockers were a distant second (17.81%), while Misoprostol was not used at all. Conclusion: NSAIDs are commonly co-prescribed with gastroprotectives. Diclofenac is the most commonly co-prescribed NSAID, while Naproxen was least commonly co-prescribed with gastroprotectives. Proton pump inhibitors were most frequently used, while Misoprostol was not used at all, probably because of its higher costs, frequent side effects and the need for multiple daily dosing.

UR - http://www.scopus.com/inward/record.url?scp=67650115024&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67650115024&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:67650115024

VL - 3

SP - 1553

EP - 1556

JO - Journal of Clinical and Diagnostic Research

JF - Journal of Clinical and Diagnostic Research

SN - 2249-782X

IS - 3

ER -